EE433 Cost-Effectiveness Analysis of a New Second-Line Treatment for Advanced Intrahepatic Cholangiocarcinoma in Taiwan: Genetic Test-Based Targeted Therapy of Pemigatinib Versus Chemotherapy of 5-FU
Abstract
Authors
CH Chueh YW Tsai ZR Chen MN Shiu NJ Chiang